O

Octant

Novel therapeutics for serious diseases

South San Francisco, United States · Founded 2019 · $110.0M raised

Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$110.0M
Last Round
$80.0M Series BApr 2022
Rounds
2

About

Octant is a therapeutics company pioneering a new type of small molecule drug discovery by using massive experimentation in human cells via its Navigator platform, which integrates synthetic biology, high-throughput chemistry, and AI/ML. The platform models how target proteins interact within cells — including signaling, transcription, and trafficking — rather than simply binding isolated proteins. Octant focuses on rare diseases and oncology driven by protein misfolding.

Summary

Octant is a Biotech company based in South San Francisco, United States, founded in 2019. It has raised $110.0M in total across 2 rounds, most recently a $80.0M Series B round in Apr 2022. Investors include Andreessen Horowitz, Catalio Capital Management and Bristol Myers Squibb.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BApr 2022
$80.0M

Sign up to see all 2 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Octant on Indexed.vc
<a href="https://indexed.vc/companies/octant"><img src="https://indexed.vc/api/badge/company/octant" alt="Octant on Indexed.vc" width="260" height="76" /></a>